Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA

Although methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) strains with reduced susceptibility to vancomycin (RVS-MRSA; including vancomycin-intermediate S. aureus [VISA] and heterogeneous VISA [hVISA]) have been linked with vancomycin treatment failure, it is unclear whether they are...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Horne, K. C., Howden, B. P., Grabsch, E. A., Graham, M., Ward, P. B., Xie, S., Mayall, B. C., Johnson, P. D. R., Grayson, M. L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2009
Soggetti:
Clinical Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2715624/
https://ncbi.nlm.nih.gov/pubmed/19506056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01365-08
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi